Foreign-Trade Zone 59, Temporary/Interim Manufacturing Authority, Novartis Consumer Health, Inc., (Pharmaceutical Product Manufacturing); Notice of Approval

---
identifier: "/us/fr/2012-9357"
source: "fr"
legal_status: "authoritative_unofficial"
title: "Foreign-Trade Zone 59, Temporary/Interim Manufacturing Authority, Novartis Consumer Health, Inc., (Pharmaceutical Product Manufacturing); Notice of Approval"
title_number: 0
title_name: "Federal Register"
section_number: "2012-9357"
section_name: "Foreign-Trade Zone 59, Temporary/Interim Manufacturing Authority, Novartis Consumer Health, Inc., (Pharmaceutical Product Manufacturing); Notice of Approval"
positive_law: false
currency: "2012-04-18"
last_updated: "2012-04-18"
format_version: "1.1.0"
generator: "[email protected]"
agency: "Commerce Department"
document_number: "2012-9357"
document_type: "notice"
publication_date: "2012-04-18"
agencies:
  - "Commerce Department"
  - "Foreign-Trade Zones Board"
fr_citation: "77 FR 23222"
fr_volume: 77
docket_ids:
  - "Docket T-2-2012"
---


#  Foreign-Trade Zone 59, Temporary/Interim Manufacturing Authority, Novartis Consumer Health, Inc., (Pharmaceutical Product Manufacturing); Notice of Approval

On January 12, 2012, the Executive Secretary of the Foreign-Trade Zones (FTZ) Board filed an application submitted by the Lincoln Foreign Trade Zone, Inc., grantee of FTZ 59, requesting temporary/interim manufacturing (T/IM) authority, on behalf of Novartis Consumer Health, Inc., to manufacture pharmaceutical products under FTZ procedures within FTZ 59—Sites 3 and 4, in Lincoln, Nebraska.

The application was processed in accordance with T/IM procedures, as authorized by FTZ Board Orders 1347 (69 FR 52857, 8/30/04) and 1480 (71 FR 55422, 9/22/06), including notice in the *Federal Register* inviting public comment (77 FR 4758, 1/31/2012). The FTZ staff examiner reviewed the application and determined that it meets the criteria for approval under T/IM procedures. Pursuant to the authority delegated to the FTZ Board Executive Secretary in the above-referenced Board Orders, the application is approved, effective this date, until March 27, 2014, subject to the FTZ Act and the Board's regulations, including Section 400.28.

Dated: March 27, 2012.

Andrew McGilvray,

Executive Secretary.